Long-term mortality after acute stroke  Stroke is a leading cause of mortality: 6 million fatal events annually worldwide.  Mainly affects elderly, but.

Slides:

Advertisements

Similar presentations

WHO CVD Atlas WHO Stroke Atlas The Burden of CVD in Asia: Stroke Deaths by Country,

Advertisements

Clinical Trial Results. org Tilman B. Drüeke, M.D.; Francesco Locatelli, M.D.; Naomi Clyne, M.D.; Kai-Uwe Eckardt, M.D.; Iain C. Macdougall, M.D.; Dimitrios.

Andrew W. Asimos, MD, FACEP Transient Ischemic Attack Patient Update: The Optimal Management of Emergency Department Patients With Suspected Cerebral Ischemia.

Atrial Fibrillation in Patients with Cryptogenic Stroke Gladstone DJ et al. N Engl J Med 2014; 370: Presented by Kris Huston | July 21, 2014.

CAPRIE: Clopidogrel versus Aspirin in Patients at risk of Ischemic Events Purpose To assess the relative efficacy of the antiplatelet drugs clopidogrel.

TNT: Study Design Treating to New Targets 2 5 years 10,001 Patients Clinically evident CHD LDL-C 130  250 mg/dL following up to 8-week washout and 8-week.

Slide Source: Lipids Online Slide Library Prospective Study of Pravastatin in the Elderly at Risk (PROSPER) 5804 patients aged 70–82.

Stroke Issues & prevention. Agenda  Impact of Stroke –Definitions –Epidemiology –Risk factors  Management of Stroke –Acute management –Primary & Secondary.

1.A 33 year old female patient admitted to the ICU with confirmed pulmonary embolism. It was noted that she had elevated serum troponin level. Does this.

1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2011.

Efficacy and safety of angiotensin receptor blockers: a meta-analysis of randomized trials Elgendy IY et al. Am J Hypertens. 2014; doi:10,1093/ajh/hpu209.

Measures of disease frequency (I). MEASURES OF DISEASE FREQUENCY Absolute measures of disease frequency: –Incidence –Prevalence –Odds Measures of association:

TOTAL Stroke in the TOTAL trial: Randomized trial of manual aspiration Thrombectomy in STEMI TOTAL Trial Investigators.

OVBIAGELE B, DIENER H-C, YUSUF S, ET AL., PROFESS INVESTIGATORS. LEVEL OF SYSTOLIC BLOOD PRESSURE WITHIN THE NORMAL RANGE AND RISK OF RECURRENT STROKE.

Stroke - the size of the problem. What is a stroke? What is a transient ischaemic attack? What is the size of the problem?

Edward P. Sloan, MD, MPH, FACEP EMRA /FERNE Case Conference: The ED Management of TIA, AIS and ICH Patients.

Body Mass Index, Weight Change and Death in an Older Hypertensive Population: The SHEP Study Grant W Somes Stephen B Kritchevsky Marco Pahor Ronald I Shorr.

1 Journal Club Alcohol, Other Drugs, and Health: Current Evidence July–August 2012.

BEAUTI f UL: morBidity-mortality EvAlUaTion of the I f inhibitor ivabradine in patients with coronary disease and left ventricULar dysfunction Purpose.

Randomized, double-blind, multicenter, controlled trial.

EPIB-591 Screening Jean-François Boivin 29 September

Measurement Measuring disease and death frequency FETP India.

Measuring disease and death frequency

‘STROKE’ February 2011 Dr Amer Jafar ABHB/Gwent. Decreased Kidney Function  Chronic kidney disease is an important risk factor for development and progression.

Acute Stroke: Principles of Modern Management A program of the American Academy of Neurology The AAN Acute Stroke Management courses are supported in part.

Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.

1 ENTEREG ® (Alvimopan) Special Safety Section Marjorie Dannis, M.D. Division of Gastroenterology Products Office of Drug Evaluation III CDER, FDA The.

Vascular events In noncardiac Surgery patIents cOhort evaluatioN study (NCT ) The Study Otavio Berwanger, Yannick Lemanach, Erica Aranha Suzumura,

Rates, Ratios and Proportions and Measures of Disease Frequency

Cerebro-Vascular Pathology of Elderly diabetics 72 case-studies S. Hannat - R. Chermat - R. Malek Internal Medical Service University Hospital Centre Setif.

The ACTIVE Investigators. N Engl J Med 2009 Apr 3 [Epub]

PJ Devereaux, Population Health Research Institute, Hamilton, Canada on behalf of POISE-2 Investigators PeriOperative ISchemic Evaluation-2 Trial POISE-2POISE-2.

DR AMER JAFAR ‘STROKE’ October Ethnicity and recurrence of stroke Population-based study Compared poststroke recurrence and survival in Mexican.

Lecture 5: The Natural History of Disease: Ways to Express Prognosis

Measures of Disease Frequency

Logo Authors & Affiliations : Josep L Clua-Espuny (1), Teresa Forcadell-Arenas (1), Rosa Ripolles-Vicente (1), Panisello-Tafalla(1), Antonia González-Henares.

Incidence and prognosis of hepatocellular adenoma in Denmark Lars Bossen Departments of Hepatology and Gastroenterology and Clinical Epidemiology Aarhus.

1 CONFIDENTIAL – DO NOT DISTRIBUTE ARIES mCRC: Effectiveness and Safety of 1st- and 2nd-line Bevacizumab Treatment in Elderly Patients Mark Kozloff, MD.

Long-term mortality and thrombolysis therapy after a first acute ischemic stroke: gender differences. Ebrictus II Study. Authors & Affiliations Clua-Espuny.

Hypothesis: baseline risk status of the patients and proximity to a recent cardiovascular event influence the response to dual anti-platelet therapy. Patients.

Rosuvastatin 10 mg n=2514 Placebo n= to 4 weeks Randomization 6weeks3 monthly Closing date 20 May 2007 Eligibility Optimal HF treatment instituted.

Results of mortality analyses, 1980 – 2003 years (Observed deaths: Obs; expected deaths: exp; Standardized Mortality Ratios: SMR) * statistically significant.

以多重死因資料比較台灣美國腦中風併發吸入性肺炎之趨勢奇美醫學中心張嘉祐醫師. Stroke Statistics -- A Report From the American Heart Association Approximately 56% of stroke deaths in 2009.

Unnecessary Lipid Screening of Inpatient Admissions Dennis Whang 4/2/12 DSR2.

Self-rated Health and Mortality Risk in the Oldest Old in China Chinese Longitudinal Healthy Longevity Study Liu Yuzhi, Li Qiang Institute of Population.

Peripheral Artery Disease in Orthopaedic Patients with Asymptomatic Popliteal Artery Calcification on Plain X-ray Adam Podet, MS; Julia Volaufova, phD,;

Women reaching equality in health, despite the differences Nowadays women remain the largest CAD population subgroup being under-diagnosed and under-treated.

The AURORA Trial Source: Holdaas H, Holme I, Schmieder RE, et al. Rosuvastatin in diabetic hemodialysis patient. J Am Soc Nephrol. 2011;22(7):1335–1341.

Objective Bleeding events are grave and sometimes life threatening complications after prosthetic valve replacement, especially in hemodialysis patients.

Reducing Tobacco Intake Lowers Risk of Lung Cancer in Heavy Smokers Slideset on: Godtfredsen NS, Prescott E, Osler M. Effect of smoking reduction on lung.

CHEST 2013; 144(3): R3 김유진 / Prof. 장나은. Introduction 2  Cardiovascular diseases  common, serious comorbid conditions in patients with COPD cardiac.

Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use and Outcomes of Triple Therapy Among Older Patients.

Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Trends, Predictors, and Outcomes of Cerebrovascular.

Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: The Bleeding Risk and Natural History of Idiopathic.

R2. 최태웅 / Pf. 김진배. BACKGROUND  Ischemic stroke : leading causes of death and disability : cause remains unexplained after routine evaluation → Cryptogenic.

Use of Azithromycin and Death from Cardiovascular Causes Whitney Shirley University of Georgia Pharm.D. Candidate 2014.

Stroke, Bleeding, and Mortality Risks in Elderly Medicare Beneficiaries Treated with Dabigatran or Rivaroxaban for Nonvalvular Atrial Fibrillation.

Low-Dose Aspirin for Primary Prevention of Cardiovascular Events in Patients With Diabetes: A Meta-Analysis Stavros Stavrakis, MD The American Journal.

SOCRATES Trial design: Patients with acute ischemic stroke were randomized in a 1:1 fashion to receive either ticagrelor 180 mg load + 90 mg BID or aspirin.

All-Cause and Cause-Specific Mortality in Patients with Psoriasis in Taiwan: A Nationwide Population-Based Study Meng-Sui Lee, Yi-Chun Yeh, Yun-Ting.

Teaching Tool: Blood Pressure Classification

Progress and Promise in RAAS Blockade

DANISH Trial design: Patients with nonischemic cardiomyopathy were randomized to ICD implantation (n = 556) versus usual care (n = 560). Results (p = 0.28)

Prevalence and Significance of Unrecognized Renal Dysfunction in Patients with Stroke David Pereg, MD, Zach Rozenbaum, MD, Dina Vorobeichik, MA, Nir Shlomo,

George E. Kikano, MD, Marie T. Brown, MD Mayo Clinic Proceedings

Lowering of SBP by 20 mm Hg Reduces Cardiovascular Risk by Half

MATCH Results: Implications for the Internist

Emerging Risk Factors Collaboration. JAMA 2009;302:412-23

Simvastatin in Patients With Prior Cerebrovascular Disease: HPS

Alcohol, Other Drugs, and Health: Current Evidence

Presentation transcript:

Long-term mortality after acute stroke  Stroke is a leading cause of mortality: 6 million fatal events annually worldwide.  Mainly affects elderly, but 10% of strokes are in patients younger than 50 years.  Prognosis of stroke is usually considered benign in the young population when compared with older patients who have a higher short-term rate of mortality.  But… there is no direct evaluation of the impact of stroke in patients younger than 50 years old compared with age-matched individuals from the general population.

The FUTURE study  Follow-Up of Transient ischemic attack and stroke patients and Unelucidated Risk factor Evaluation (FUTURE): a prospective cohort study. 1  Objective: to investigate long-term mortality and cause of death after acute stroke in adults aged 18 through 50 years and to compare this with age and sex- matched mortality rates in the Netherlands.  959 Consecutives’ patients with first-ever transient ischemic attack (TIA, n=262), ischemic stroke (n=606), and intracerebral hemorrhage (ICH, n=91), followed up over a mean duration of 11.1 years. Population distribution 1- Rutten-Jacobs LC, Arntz RM, Maaijwee NA et al. Long-term mortality after stroke among adults aged 18 to 50 years. JAMA. 2013;309(11):

Observed rate of death in the FUTURE study  During follow-up, 192 patients died.  Case-fatality 43 Patients died during the first 30 days, providing a 30-day case-fatality rate of 0.4% after TIA, 3.6% after ischemic stroke, and 22% after ICH.  Long-term mortality in 30-day survivors Cumulative mortality over 20 years in young patients were respectively 24.9% (95% confidence interval [CI], ) after TIA, 26.8% (95% CI, ) after ischemic stroke, and 13.7% (95% CI, ) after ICH.

 Mortality after ischemic stroke remained increased compared with the expected mortality during the entire follow-up: For TIA: 24.9% (95% CI, ) vs 8.5% For ischemic stroke: 26.8% (95% CI, ) vs 7.6% For ICH: 13.7% (95% CI, ) vs 5.6%  The standardized mortality ratio (SMR) reflected the increased mortality observed in all subgroups compared with expected values. PatientsPatient-yearsObservedExpected SMR (95% CI) P value TIA ( ) P<0.001 Ischemic stroke ( ) P<0.001 ICH ( ) P<0.001 Long-term consequence of stroke on death rate

Conclusion  Patients experiencing a stroke between the ages of 18 and 50 years remain at significantly higher risk of death compared with the general population during the 20 following years.  Half of the deaths were attributable to a vascular event, suggesting that the underlying disease causing stroke at a young age continues to be active throughout life.  Among stroke subtypes, cardioembolic stroke (part of the ischemic stroke group) was the most important predictor of mortality.